Serum alpha-foetoprotein level predicts treatment outcome in chronic hepatitis C. [electronic resource]
Producer: 20071019Description: 797-803 p. digitalISSN:- 1359-6535
- Administration, Oral
- Adult
- Antiviral Agents -- administration & dosage
- Biomarkers -- blood
- Drug Administration Schedule
- Drug Therapy, Combination
- Egypt
- Female
- Hepatitis C, Chronic -- blood
- Humans
- Injections, Subcutaneous
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Linear Models
- Male
- Middle Aged
- Odds Ratio
- Patient Selection
- Polyethylene Glycols -- administration & dosage
- Proteins -- metabolism
- Recombinant Proteins
- Ribavirin -- administration & dosage
- Time Factors
- Treatment Outcome
- Viral Load
- Virus Replication -- drug effects
- alpha-Fetoproteins
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.